It’s a wrap for #SITC24! These past few days have been busy and insightful - we were pleased to demo our OI Suite, showcasing how researchers and diagnostics developers can use a user-friendly, intuitive platform to rapidly and independently develop downstream applications, even with minimal data. Next up, we’re heading to the AI Driven Drug Discovery Summit, where Jessica Riley will join an exclusive AI workshop panel discussion on Thursday, November 14, from 8–9am. Limited spots are available! Reserve yours now: https://lnkd.in/eMxB9_EB #AIDDD #OncologyIntelligence #DrugDiscovery #AIinHealthcare #PrecisionOncology
关于我们
Imagene was founded with a clear mission to leverage AI to profile, within minutes, a broad range of cancer biomarkers from a digitized biopsy image alone. By doing so we can overcome economical, logistical, and technological barriers to reach the full potential of precision medicine for all cancer patients. Imagene's technology classifies patterns that cannot be seen by the human eye, evolving genomics, proteomics, and spatial insights resulting in a fast and accurate molecular profiling. Our technology also enables better stratification of patients for clinical trials and the discovery of novel targets for new drugs. We are a diverse startup with bright, passionate and most of all fun team. Our success derives from our cutting-edge technology and talented multidisciplinary team of data scientists, biologists, software engineers, and medical experts. Imagene collaborates with top-tier medical centers and pharmaceutical companies worldwide. The fight against cancer is profound and the world needs talented and innovative people - If you are looking for a meaningful and challenging job – Join Us!
- 网站
-
https://imagene-ai.com
Imagene的外部链接
- 所属行业
- 医疗和诊断实验室
- 规模
- 11-50 人
- 总部
- Philadelphia ,PA
- 类型
- 私人持股
- 创立
- 2020
地点
Imagene员工
-
Avital Rabani
B2B Marketer and Strategist, VP of Marketing @Imagene
-
Addie Dvir
Personalized medicine leader, Next generation AI image-based molecular analysis
-
Emre Gültürk
VP of Regulatory Affairs and Quality Systems at Heartflow
-
Will Brown, MBA
Business & Commercial Operations Leader in Life Science, Pharma & Healthcare Technology. Adjunct Professor of Business & Entrepreneurship.
动态
-
Imagene转发了
The visit from Dr. Michael Lotze at our Imagene booth during #SITC was truly an honor. His pivotal contributions to the field of immunotherapy have been groundbreaking, spanning from the early days of IL2 therapy to advancements in Natural Killer Cells (NKs), lymphokine-activated killer cells, tumor-infiltrating lymphocyte infusions, and cutting-edge gene and cell therapies. Dr. Lotze's expertise has played a fundamental role in shaping the landscape of immunotherapy. It was incredibly inspiring to hear his positive outlook on #AI and its role in accelerating and enhancing the development of novel therapies and #diagnostics, in immunotherapy. He also emphasized the critical need to bridge industry and academia—a vision that aligns closely with our goals at Imagene. Amazing to have the opportunity to learn from a unique pioneer in the field of immunotherapy. #Immunotherapy #celltherapy #clinicaltrials
-
We’re excited to be on-site at #SITC24! Stop by Booth #1139 to meet our team and see a demo of our OI Suite, enabling rapid generation of downstream tasks and supporting a wide range of hypotheses in minutes - even with minimal data. Dean Bitan Jessica Riley Addie Dvir
-
Imagene转发了
Thrilled to have had Dr. Eun Yeong Oh, MD, PhD visit us at the Imagene booth following her inspiring talk at #PathologyVisions! Her candid insights into her journey of implementing digital pathology in her health system were remarkable. Through determination, she managed to “fight windmills” and overcome the challenges associated with this transformation. Thanks to her vision and leadership her hospital achieved: * Reduced burden of specimen deliveries * Accelerated turnaround time for diagnoses and treatment * Improvements in patient and clinician satisfaction * Built the infrastructure for AI solutions development * Ranked #4 in hospital AI readiness One quote from Dr. Oh’s presentation that truly resonated with me was a Steve Jobs classic: “People don’t know what they want until you show it to them.” Her journey exemplifies this idea, showing the potential of digital pathology when met with a pioneering spirit. Thank you, Dr. Oh, from Mid-Atlantic Permanente Medical Group | Kaiser Permanente for sharing your experience! Imagene is excited to support this wave of innovation in healthcare. #PathologyVisions #DigitalPathology #HealthcareInnovation #AIinHealthcare
-
It’s a wrap for #PathVisions24, and we’re off to #SITC2024 in Houston! Reflecting on Pathology Visions, this year, there was a strong focus on AI-driven image analysis for biomarkers, but discussions also covered the practicalities - reimbursement, regulation, and the need for an open ecosystem to drive real adoption. It’s clear that for AI to succeed, evidence-based approaches and digital pathology are essential, with advances in multi-modal AI , LLMs, and foundation models suggesting that a comprehensive, AI-enabled pathology workflow is becoming an achievable reality. We’re excited to bring this momentum to #SITC! Visit us at booth #1139 to meet with Dean Bitan, Jessica Riley, and Addie Dvir, and see how our OI Suite platform can accelerate your AI research. Gain insights, explore hypotheses, and expand your data in minutes - even with minimal data. Don’t miss out - set up a meeting here: https://lnkd.in/eaj8Szyp #SITC24 #Immunotherapy #CancerResearch #OncologyResearch Society for Immunotherapy of Cancer (SITC)
-
Wrapping up an exciting first day at #PathVisions24! It’s been a pleasure connecting with so many in the pathology community and sharing how OI Suite empowers researchers to accelerate discoveries in oncology. Thank you to everyone who stopped by to learn how our intuitive, data-efficient AI solutions can help tackle complex research questions with ease. Join us again tomorrow at Booth #1139 or schedule a demo meeting to dive deeper into OI Suite's capabilities: https://lnkd.in/dCpYxUHp Looking forward to more insightful conversations on Day 2! Addie Dvir - Head of Diagnostics, Imagene
-
Imagene is excited to participate in the Exclusive AI Workshop at the AI Driven Drug Discovery Summit on November 14! Join Jessica Riley, as she shares insights on ethical AI and responsible innovation in drug discovery, exploring how Imagene’s Oncology Intelligence leverages responsible AI to decode cancer and drive precision oncology forward. This session is a must-attend for those in biopharma, biotech, or AI who are committed to advancing healthcare with integrity and innovation. Limited spots are available! Reserve yours now: https://lnkd.in/eMxB9_EB #AIDDD #OncologyIntelligence #DrugDiscovery #AiinHealthcare #PrecisionOncology ? ?
Join the Ethical AI Workshop at the AI Driven Drug Discovery Summit on Thursday, November 14! We're thrilled to announce an exclusive partnership with the The Alliance for Artificial Intelligence in Healthcare (AAIH), bringing an in-depth workshop on Ethical AI in Drug Discovery.?Whether you're in biopharma, biotech, or AI, this session is a must-attend for anyone dedicated to responsible and innovative healthcare solutions! What to Expect: ? Working Breakfast with Industry Leaders ?? Panel Discussions on AI ethics with experts from biopharma, biotech, and AI sectors ?? Real-World Case Studies to bridge innovation with ethical frameworks and regulatory alignment Key Takeaways: Navigate Ethical AI in life sciences and pharma Learn from Success Stories shaping the future of healthcare Build Actionable Strategies for responsible AI implementation in your organization Meet Our Expert Speakers: Ari Caroline, CEO & Co-Founder, Weave Jessica Riley, Chief Business Officer, Imagene Isaac Bentwich, MD, Founder & CEO, Quris Daniel Pointing, Associate Director Business Development and Strategy, Genialis This exclusive workshop has limited spaces! Register now and ensure your place at the forefront of ethical AI in healthcare: https://lnkd.in/eMxB9_EB #AIDDD #aidrivendrugdiscovery #aidrugdiscovery
-
?? 4 Days to #PathVisions24! We're excited to showcase OI Suite, our powerful platform that gives researchers access to an industry-leading histology foundation model. With its intuitive, user-friendly interface, OI Suite enables rapid custom model development using your data, even with minimal labeled data. Leverage AI models to independently produce cutting-edge studies at scale, publishing novel insights faster and reducing data burdens - all without needing AI expertise. Schedule a demo meeting to see it in action: https://lnkd.in/dCpYxUHp Addie Dvir - Head of Diagnostics, Imagene
-
?? #SITC2024 is just 10 days away! ?? Join us at booth #1139 to connect with our executive team and discover how our OI Suite platform can transform your AI research. Accelerate insights, expand your data, and explore a wide range of research hypotheses in minutes - even with minimal data. Don't miss out - set up a meeting here: https://lnkd.in/d8AD2nhQ Dean Bitan, Jessica Riley, Addie Dvir #SITC24 #Immunotherapy #CancerResearch #OncologyResearch Society for Immunotherapy of Cancer (SITC)
-
Thank you Oracle Cloud team for collaborating with us on our mission to make AI accessible through #OCI, transforming cancer research and diagnostics - accelerating research and enabling rapid, innovative discoveries. Your work in capturing and sharing our story highlights the profound impact AI is having in this space. Michael Hickins Yamini Bhagavatula Michael Egbert Kevin Bossi
Imagene transforms precision oncology by using OCI to help cancer researchers and developers create advanced #AI models, regardless of their AI expertize or #data availability: https://lnkd.in/eAj9wsbR